The abstract is read at the publisher; the summary is JClub's.
Annual universal COVID-19 vaccination timed to July reduced COVID-19 hospitalizations in adults aged ≥65 years to 441 per 100,000 versus 578 with no additional vaccination.
- Why it matters: With COVID-19 shifting to summer predominance in much of the US, policymakers need evidence on how changing vaccination timing, eligibility, and dosing frequency affects hospitalization burden.
- What they did: A decision analytical, stochastic individual-based transmission model calibrated to US hospitalization incidence from May 2024–April 2025 simulated a 5 million-person population with age and risk stratification under alternative strategies.
- The result: Summer timing’s advantage diminished when vaccine coverage fell by 5–10 absolute percentage points, and the benefit of summer timing and semiannual dosing in highest-risk groups varied regionally.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.